Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000210739

Medchemexpress LLC 3H-imidazo[4,5-b]pyridine, 2-ethyl-5,7-dimethyl- | 133240-06-9 | 99.4% | 175.24 g/mol | C10H13N3 | 50 MG
SDP

Catalog No. 5000210739
Encompass_Preferred

Adenosine receptor antagonist 4 (compound 2) is a small-molecule adenosine A1 receptor antagonist reported with a Ki of 101 nM for the human A1 receptor. It is provided for research use and is characterized by a defined molecular formula and high purity suitable for in vitro pharmacology and receptor-binding studies.

  • Cas number 133240-06-9.
  • Molecular formula C10H13N3 and molecular weight 175.24 g/mol.
  • Purity (HPLC) 99.35%.
  • Available in solution (10 mM in DMSO) and solid sizes including 25 mg, 50 mg, and 100 mg.
  • Batch-specific COA, data sheet, and SDS are available for handling and quality information.

Catalog No. 50-002-10739 Supplier Medchemexpress LLC Supplier No. HYW06319750MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

Adenosine receptor antagonist 4 (compound 2) is a small-molecule adenosine A1 receptor antagonist reported with a Ki of 101 nM for the human A1 receptor. It is provided for research use and is characterized by a defined molecular formula and high purity suitable for in vitro pharmacology and receptor-binding studies.

  • Cas number 133240-06-9.
  • Molecular formula C10H13N3 and molecular weight 175.24 g/mol.
  • Purity (HPLC) 99.35%.
  • Available in solution (10 mM in DMSO) and solid sizes including 25 mg, 50 mg, and 100 mg.
  • Batch-specific COA, data sheet, and SDS are available for handling and quality information.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.